Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activation of PPARγ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells

PLoS ONE(2020)10.1371/journal.pone.0237976Source: DataRank Database

Activation of PPARγ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.98)OA: goldTopics (88)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Nicholas Bergum,Peter Knutson,Swojani Shrestha ORCID,Xu Zhou ORCID,Scott H. Garrett ORCID

Live enrichment

PubMed:32822399 PMC:PMC7444546 OpenAlex:https://openalex.org/W3080742738

National Institute of General Medical Sciences

Grant: P20 GM103442

National Institutes of Health

Grant: 3P20GM103442-19A1S1

ND INBRE Health & the Environment

FWCI

0.98

Citation Percentile

0.8%

Citation Trend

2020

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0237976&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0237976&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0237976

journalhttps://doi.org/10.1371/journal.pone.0237976

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32822399

Fields of Study

Bladder and Urothelial Cancer TreatmentsGenomics, phytochemicals, and oxidative stressCancer, Lipids, and Metabolism03 medical and health sciences0302 clinical medicineAnimalsArsenitesBiomarkers, TumorCell Line, TumorCell ProliferationDown-RegulationErbB ReceptorsHepatocyte Nuclear Factor 3-alphaHumansKeratinsMiceMice, NudePPAR gammaQuinazolinesTranscription FactorsTranscriptomeTransplantation, HeterologousTroglitazoneUp-RegulationUrinary Bladder Neoplasms

MeSH Terms

TroglitazoneAnimalsUrinary Bladder NeoplasmsHumansKeratinsMice, NudeQuinazolinesTranscription FactorsTransplantation, HeterologousBiomarkers, TumorDown-RegulationUp-RegulationArsenitesCell Line, TumorPPAR gammaCell ProliferationMiceHepatocyte Nuclear Factor 3-alphaTranscriptomeErbB Receptors

Keywords

BiologyCancer researchFOXA1Epidermal growth factor receptorPeroxisome proliferator-activated receptorBladder cancerPeroxisome proliferator-activated receptor gammaKeratin 5CancerInternal medicineMolecular biologyEndocrinologyGene expressionReceptorImmunohistochemistryImmunologyMedicineGeneBiochemistryHepatocyte Nuclear Factor 3-alphaArsenitesScienceTransplantation, HeterologousDown-RegulationMice, NudeMiceTroglitazoneCell Line, TumorBiomarkers, TumorAnimalsHumansCell ProliferationQRUp-RegulationErbB ReceptorsPPAR gammaUrinary Bladder NeoplasmsQuinazolinesKeratinsTranscriptomeResearch ArticleTranscription Factors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being